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RecallCortisol’s effects on memory follow an inverted U-shaped function such that memory retrieval is
impaired with very low concentrations, presumably due to insufﬁcient activation of high-afﬁne miner-
alocorticoid receptors (MR), or with very high concentrations, due to predominant low-afﬁne glucocorti-
coid receptor (GR) activation. Through corresponding changes in re-encoding, the retrieval effect of
cortisol might translate into a persistent change of the retrieved memory. We tested whether partial sup-
pression of morning cortisol synthesis by metyrapone, leading to intermediate, circadian nadir-like levels
with presumed predominant MR activation, improves retrieval, particularly of emotional memory, and
persistently changes the memory. In a randomized, placebo-controlled, double-blind, within-subject
cross-over design, 18 men were orally administered metyrapone (1 g) vs. placebo at 4:00 AM to suppress
the morning cortisol rise. Retrieval of emotional and neutral texts and pictures (learned 3 days earlier)
was assessed 4 h after substance administration and a second time one week later. Metyrapone sup-
pressed endogenous cortisol release to circadian nadir-equivalent levels at the time of retrieval testing.
Contrary to our expectations, metyrapone signiﬁcantly impaired free recall of emotional texts (p < .05),
whereas retrieval of neutral texts or pictures remained unaffected. One week later, participants still
showed lower memory for emotional texts in the metyrapone than placebo condition (p < .05). Our
ﬁnding that suppressing morning cortisol to nadir-like concentrations not only impairs acute retrieval,
but also persistently weakens emotional memories corroborates the concept that retrieval effects of
cortisol produce persistent memory changes, possibly by affecting re-encoding.
 2015 The Authors. Published by Elsevier Inc. This is anopenaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cortisol is a potent modulator of memory, which differentially
affects processes of encoding, consolidation, and retrieval
(de Quervain, Aerni, Schelling, & Roozendaal, 2009; Kelemen,
Bahrendt, Born, & Inostroza, 2014; Schwabe, Joels, Roozendaal,
Wolf, & Oitzl, 2011). Generally, it enhances encoding of informa-
tion, but impairs memory retrieval, especially of negative material.
Of note, memory retrieval is not only impaired at strongly elevated
cortisol levels (de Quervain, Roozendaal, & McGaugh, 1998; de
Quervain, Roozendaal, Nitsch, McGaugh, & Hock, 2000; Domes,
Rothﬁscher, Reichwald, & Hautzinger, 2005; Kuhlmann, Piel, &
Wolf, 2005), but also at minimum levels after suppression ofcortisol synthesis by metyrapone (Marin, Hupbach, Maheu,
Nader, & Lupien, 2011; Rimmele, Meier, Lange, & Born, 2010), sug-
gesting an inverted U-shaped function that describes the relation-
ship between memory retrieval and cortisol concentrations
(Schilling, Kolsch, Larra, Zech, Blumenthal, Frings, & Schachinger,
2013). The inverted U-shaped response function has been linked
to an imbalance in mineralocorticoid receptor (MR) and glucocor-
ticoid receptor (GR) activation with both enhanced GR activation at
high cortisol levels and reduced MR activation at very low cortisol
levels mediating impairing effects on retrieval. In line with this
notion, administration of metyrapone at a dose of 3 g almost com-
pletely suppressed endogenous cortisol release, and this was
accompanied by a signiﬁcantly impaired free recall of texts and
pictures, in particular when emotional (Rimmele et al., 2010).
Thus, optimal memory retrieval is expected when MRs are occu-
pied to a great extent, but not GRs, i.e. conditions presumably
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Oitzl, & Joels, 1999; Lupien, Maheu, Tu, Fiocco, & Schramek, 2007).
Besides an acutely impairing effect on retrieval, there is ﬁrst evi-
dence that the impairing effect of metyrapone on memory retrieval
persists beyond the acute period of cortisol suppression and is still
present at a second retrieval test 4 days later (Marin et al., 2011).
That study showed a persisting decrease of emotional, but not neu-
tral memories for pictures with 1.5 g of metyrapone, but not with
0.75 g ofmetyrapone given before the ﬁrst retrieval of the testmate-
rials. Salivary cortisolmeasures indicated that a signiﬁcant suppres-
sion of cortisol was achieved only after the 1.5 g dosis.
Here, we tested the effect of metyrapone-induced cortisol inhi-
bition during the morning hours on acute retrieval and the persis-
tence of this effect over an even longer 1-week interval. Adopting
the framework of an MR/GR activation balance that determines
the direction of glucocorticoid effects, we chose a dose of 1 g
metyrapone. Based on pilot studies and our previous work
(Rimmele et al., 2010), this dose was expected to only partially
block cortisol release and to induce cortisol levels comparable with
those during the circadian nadir of pituitary-adrenal activity where
MRs are estimated to be occupied by 50–70%, in the absence of
substantial GR occupation (Kalman & Spencer, 2002; Reul & de
Kloet, 1985; Spencer, Miller, Moday, Stein, & McEwen, 1993). We
expected that such predominance of MR over GR occupation would
acutely enhance memory retrieval. Assuming that the effect on
retrieval goes along with a parallel effect on re-encoding, we fur-
ther expected that the acute enhancement in retrieval after metyr-
apone would persist during a second retrieval test 1 week later.2. Methods
2.1. Participants
Eighteen healthy native German-speaking men (mean age
22.17 ± 2.50 years; mean body mass index 22.92 ± 1.65 kg/m2) par-
ticipated in the double-blind, within-subject cross-over study,
which was approved by the local ethics committee. Subjects pro-
vided informed consent and were paid for participation.2.2. Procedure and memory tasks
Each participant was tested in two conditions (metyrapone vs.
placebo), separated by an interval of at least 12 days, with the
order of conditions balanced across subjects. Each condition
included a learning session and two retrieval sessions (Fig. 1A).
In the learning session (9:00–11:00 AM), participants memorized
emotional and neutral texts (Wagner, Degirmenci, Drosopoulos,
Perras, & Born, 2005) and pictures (Lang, 1999). Substance admin-
istration took place at 4:00 AM before the ﬁrst retrieval session
(between 7:45 AM and 9:00 AM, 3 days after the learning session).
To this end, subjects slept in the laboratory (lights off at 11:00 PM)
and were shortly awakened for oral administration of either
metyrapone (1 g, Novartis Pharma, Switzerland, half life in plasma
20–120 min) or placebo. Retrieval of the texts took place between
7:45 AM and 8:30 AM, and retrieval of the pictures between
8:30 AM and 9:00 AM. Cortisol, ACTH, epinephrine and nore-
pinephrine levels were assessed repeatedly in blood sampled at
2:00 AM and 3:30 AM, and following substance administration
every 30 min from 4:30 AM until 10:00 AM. The second retrieval
session took place one week later in the afternoon (2:00–4:00 PM).
For assessment of text memories in each of the two learning
sessions, participants were instructed to read one emotional and
one neutral text, which were printed on a sheet of paper, thorough-
ly within 4 min (abundant time to complete the readings) and to
memorize as many details as possible for later recall. The orderof the experimental texts within a session and the order of parallel
versions on the subject’s two test occasions were balanced across
subjects. Immediately after learning, participants wrote down the
previously read text as exactly as possible in order to obtain a mea-
sure of the original encoding level. Free recall was assessed in the
same way in the ﬁrst retrieval session 3 days (after pill administra-
tion) as well as in the second retrieval session 10 days (without any
pill administration) after learning. Assessment of memory perfor-
mance was based on the number of correctly recalled content
words. Validity of this measure has been conﬁrmed in previous
experiments (Schuerer-Necker, 1994).
For assessment of picture memory in the learning session, par-
ticipants were instructed to memorize 50 negative and 50 neutral
pictures. Following the presentation of each picture for 4 s, using
the Self Assessment Manikin (1, highly positive; 9, highly negative;
1, very much arousing; 9, not at all arousing) (Bradley, Greenwald,
Petry, & Lang, 1992; Lang, 1999), emotional and neutral pictures
were rated signiﬁcantly different on valence (average rating –
emotional 5.92 ± .26; neutral 4.27 ± .18; t(14) = 6.24, p < .001) and
arousal (emotional 5.10 ± .46; neutral 6.79 ± .34; t(14) = 5.89,
p < .001). Arousal and valence ratings did not differ between the
parallel versions (all p > .19). The two sets were counterbalanced
across the metyrapone and placebo condition. Immediately after
encoding, during the ﬁrst retrieval session 3 days (after receiving
placebo or metyrapone) and the second retrieval session 10 days
after learning (without pill administration), participants’ free recall
was assessed by asking them to list, for each picture recalled, as
many details as they could remember with no time constraint.
2.3. Psychological control variables
At the beginning of the retrieval sessions, attention, mood,
calmness, wakefulness, and working memory were assessed using
the d2 letter cancellation test (Brickenkamp & Zillmer, 1998), the
Positive and Negative Affect Scale (PANAS) (Watson, Clark, &
Tellegen, 1988), the Multidimensional Mood Questionnaire
(Steyer, Schwenkmezger, Notz, & Eid, 1997), and the Digit Span
subtest (forward, backward) of the Wechsler Adult Intelligence
Scale (Wechsler, 1981). Additionally at the end of the retrieval ses-
sions, working memory was assessed with the Sternberg task as
previously described (Lupien, Gillin, & Hauger, 1999).
2.4. Hormonal measures
Blood samples were immediately centrifuged and stored at
80 C until assay. Cortisol and ACTH concentrations were assessed
using Immulite (Siemens Medical Solutions Diagnostics, Los
Angeles, CA; sensitivity .2 lg/dl for cortisol, 9 pg/ml for ACTH).
Plasma epinephrine (E) and norepinephrine (NE) were assessed
with standard high-performance liquid chromatography
(ChromSystems, Munich, Germany; sensitivity 15 pg/mL for E and
NE). Interassay coefﬁcients of variation for all assays were <10%. E
levels were mostly below detection threshold and are not reported.
2.5. Data analyses
Two independent raters, blind to treatment, quantiﬁed written
free recall. Statistical analysis was based on analyses of variance
(ANOVA) with repeated-measures factors for ‘treatment’ (metyra-
pone vs. placebo) and ‘session’ (‘learning session vs. 1st retrieval
session, and 1st vs. 2nd retrieval session, respectively) and for
the memory variables, the additional factor ‘emotionality’ (neutral
vs. emotional). For hormone levels, analyses included repeated-
measures factors ‘treatment’ and ‘time of measurement’. Where
appropriate, Greenhouse–Geisser corrections of degrees of free-
dom were used. Signiﬁcant ANOVA effects were speciﬁed by
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Fig. 1. (A) Experimental procedure. At the learning session, participants learned and immediately recalled emotional and neutral texts and pictures. Three days later, free
recall of the learned material was tested between 7:45 AM and 9:00 AM (morning cortisol rise) after administration of 1 g metyrapone or placebo at 4:00 AM. A week after
substance administration, free recall was tested again. (B) Plasma cortisol at the time of retrieval testing (7:45 AM–9:00 AM) was strongly increased after placebo, but
suppressed after administration of metyrapone at 4:00 AM. Importantly cortisol levels were more suppressed after metyrapone, but higher after placebo during text recall
(7:45–8:30 AM, gray bars) than picture recall (8:30–9:00 AM, black bars). The slight increase in cortisol observed from the time of text to the time of picture recall in the
metyrapone condition likely reﬂects a gradual weakening of the metyrapone effects due to substance degradation. In contrast, the slight decrease in cortisol observed from
the time of text to the time of picture recall in the placebo condition reﬂects the circadian cortisol decrease of the morning cortisol rise.
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a < .05. Four participants did not come to the last session.
3. Results
3.1. Memory for texts and pictures
Immediate free recall of texts at the end of the learning session,
and before any treatment, was closely comparable between condi-
tions (all p > .11). However, text memory decreased differentially
in the metyrapone vs. placebo condition from the learning to the
ﬁrst retrieval session (session x treatment interaction:
F(1,17) = 4.80; p < .05; main effect of session: F(1,17) = 29.29,
p < .001). Metyrapone acutely impaired free recall of content words
of the emotional texts (34.36 + 3.13 vs. placebo: 41.97 + 2.82
words; t(17) = 2.78, p < .05), but not of the neutral texts (p > .32
for t test; F(1,17) = 6.39, p < .05 for main effect of treatment,
Fig. 2A). At the second retrieval which took place one week later,
when the substance had been cleared from the body, participantsin the metyrapone condition still showed the memory retrieval
impairment for emotional texts (32.93 ± 2.89 recalled words in
the metyrapone condition vs. 40.43 ± 3.25 in the placebo condi-
tion; t(13) = 2.19, p < .05), but not for neutral texts (19.00 ± 2.71
words after metyrapone and 19.46 ± 2.41 words after placebo;
treatment x emotionality F(1,13) = 6.96, p < .05, Fig. 2A). Memory
did not change from the 1st to the 2nd retrieval (all p > .58).
More content words were recalled for emotional than neutral texts
during all sessions (all p < .01).
Similar to memory for texts, the number of recalled pictures
and memory for picture details was comparable between treat-
ment conditions during learning (all p > .75) and decreased from
the learning to the ﬁrst retrieval session (main effect of session:
F(1,17) = 34.06, p < .001 for number of recalled pictures,
F(1,17) = 42.16, p < .001 for details), but were not affected by treat-
ment (for respective session x treatment interactions p > .53,
Fig. 2B). Recall of pictures and picture details was comparable
between the metyrapone and the placebo condition in the two
retrieval sessions for both emotional and neutral pictures (for
BA 7 days after 
substance adminstration
~4 hrs after 
substance administration
7 days after 
substance adminstration
~4 hrs after 
substance administration
* *
Fig. 2. Effects of metyrapone (1 g) on memory retrieval. (A) Compared with placebo
(empty bars), metyrapone reduced free recall of emotional texts 3 days after
learning (black bars). This recall impairment was still evident 7 days later, when the
medication was washed out. (B) In contrast, metyrapone administration did not
affect picture recall 3 days after learning. Likewise, 7 days after metyrapone
administration, there were no differences in picture recall between conditions.
Mean ± SEM are indicated. ⁄p < .05.
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tions p > .18). During all session, more emotional than neutral
pictures and picture details were recalled (all p < .01).3.2. Hormonal measures
At the time of retrieval testing (7:30–9:00 AM), plasma cortisol
levels were strongly increased after placebo (15.82 ± .81 lg/dl) but
suppressed after administration of metyrapone (3.37 ± .37 lg/dl;
t(16) = 16.47, p < .001; Fig. 1B). At this time, levels of ACTH were
distinctly higher in the metyrapone (178.22 ± 21.58 pg/ml) than
in the placebo condition (31.21 ± 2.58 pg/ml; t(16) = 6.97;
p < .001). Plasma norephinephrine did not differ between treat-
ments (p > .62), but increased similarly in the placebo andmetyrapone condition from 2:00 AM to 10:00 AM (F(1.95,
33.07) = 57.76; p < .001 for main effect of time).
Because the differential effect of metyrapone on retrieval of
texts vs. pictures was unexpected, we more carefully compared
cortisol levels during retrieval of texts (7:45–8:30 AM) and retrie-
val of pictures (8:30–9:00 AM). Indeed, cortisol levels were more
strongly suppressed by metyrapone at the time of text recall
(3.08 ± .34 lg/dl) than during picture recall (4.30 ± .44 lg/dl,
t(17) = 9.97, p < .001; Fig. 1B), while in the placebo condition corti-
sol levels were higher during text recall (16.98 ± .86 lg/dl) than
picture recall (13.14 ± .76 lg/dl; F(1,16) = 112.5; t(16) = 8.31,
p < .001, p < .001 for treatment x time; Fig. 1B).3.3. Control variables
Measures of sleepiness after awakening (Stanford Sleepiness
Scale) (Hoddes, Zarcone, Smythe, Phillips, & Dement, 1973), atten-
tion, working memory performance, and reported mood and wake-
fulness did not differ between treatment conditions (all p > .15).
Subjects were not able to correctly identify whether they had
received metyrapone or placebo (v2 test; p > .48). No side effects
of metyrapone were observed.4. Discussion
We found that suppression of the morning cortisol rise by 1 g
metyrapone impaired free recall of emotional texts, while leaving
recall of neutral texts or of emotional and neutral pictures unaf-
fected. This impairment was still evident at a second retrieval test,
taking place one week after substance administration.
The present study originated from the assumption that the bal-
ance between MR and GR activation determines glucocorticoid
effects on memory retrieval (Harris, Holmes, de Kloet, Chapman, &
Seckl, 2013; Rimmele, Besedovsky, Lange, & Born, 2013). MRs show
distinctly higher afﬁnity to cortisol than GRs and thus are pre-
dominantly occupied at times of low endogenous cortisol release,
as during the early night when the 24-h cortisol nadir is reached
in humans (Reul & de Kloet, 1985; Spencer et al., 1993). In previous
studies blocking endogenous cortisol synthesis almost completely
with a threefold higher dose (3 g) ofmetyrapone or directly blocking
mineralocorticoid receptors with spironolactone robustly impaired
emotional memory retrieval, a ﬁnding that we ascribed to insufﬁ-
cient MR activation (Rimmele et al., 2010, 2013). By contrast, GR
activation is predominant during times of high endogenous cortisol
like during stress. At such high cortisol levels, memory retrieval has
also been found to be impaired (de Quervain et al., 2000; Kuhlmann
et al., 2005). Collectively these observations suggest that impaired
retrieval can be caused by insufﬁcient MR activity or too much GR
activity. Here, we aimed to investigate the middle part rather than
theouter parts of the invertedU-shaped functionbyusing adistinct-
ly lower dose (1 g) ofmetyrapone in order to induce only amoderate
reduction of cortisol to levels comparable with those normally pre-
sent around the circadian cortisol nadir. Such a levelwas expected to
be associated with predominant MR over GR activation and thus to
improvememory retrieval. However, although a suppression of cor-
tisol within the normal physiological range similar to the circadian
nadir (i.e., to 3–5 lg/dl) was successfully achieved by this 1-g dose,
contrary to our prediction, emotional memory retrieval was
impaired rather than improved. Four reasonsmight explain this out-
come. First, MR might not be involved in upholding memory retrie-
val. Yet, this is unlikely given evidence that blocking MR produces a
distinct impairment of memory retrieval (Oitzl & de Kloet, 1992;
Rimmele et al., 2013; Schwabe, Schachinger, de Kloet, & Oitzl,
2010; Yau, Noble, & Seckl, 2011; Zhou, Kindt, Joels, & Krugers,
2011). Second, MR expression might be up-regulated during the
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night. In this case, even graded reductions in cortisol during the
morning would lead also to a substantial reduction in MR activity
with the effect determined by insufﬁcient MR occupation per se
rather than by relative predominance of MR over GR as we had
hypothesized. Indeed, MR expression has been found to be up-
regulated in the beginning of the active phase in rodents although
overall knowledge about the circadian MR regulation is scarce
(Reul, van den Bosch, & de Kloet, 1987). Against this backdrop, it
remains a speculation that predominant MR activation in conjunc-
tion with improved emotional memory retrieval had occurred with
even more ﬁne-tuned, slighter suppression of cortisol synthesis.
Third, while MR occupation contributes to upholding memory
retrieval, predominance of MR might not necessarily lead to an
enhancement of this function above normal baseline performance.
This view is indeed consistent with another study showing dimin-
ished retrieval of emotionalmemory after 1.5 gmetyraponewhere-
as 0.75 g remained ineffective (Marin et al., 2011), and it would also
ﬁt with the present failure of metyrapone to affect retrieval of pic-
tures as this took place at times, during which cortisol suppression
was less effective. Also direct MR agonists (like ﬂuorohydrocorti-
sone) compared to a combined activation of MRs and GRs failed to
improve retrieval function in a previous study (Tytherleigh,
Vedhara, & Lightman, 2004). Fourth, metyrapone could have inﬂu-
enced memory performance indirectly, for example by increasing
the secretion of progesterone and deoxycorticosterone (Krugers,
Maslam, Korf, Joels, & Holsboer, 2000). However, actions of these
hormones are expected to be in opposite direction on the MR
(Funder, 2005; Souque, Fagart, Couette, Davioud, Sobrio, Marquet,
& Rafestin-Oblin, 1995) and thus would not explain the current
effects.
The second main ﬁnding of this study is that the acute impair-
ment in the retrieval of emotional text memories after metyrapone
was still present at a second retrieval one week later, i.e., long after
the substance had cleared from the system, and any suppression of
cortisol synthesis was presumably absent. This ﬁnding conﬁrms
and extends a previous study showing persistence of retrieval
impairment for emotional memories over 4 days (Marin et al.,
2011) and can be well explained by metyrapone disrupting re-en-
coding. Explicit retrieval of a memory is assumed to go along with
a new encoding of the retrieved information, thus effectively
enhancing the memory trace (Nadel & Moscovitch, 1997;
Roediger & Butler, 2011). Given that cortisol supports new
encoding (Abercrombie, Kalin, Thurow, Rosenkranz, & Davidson,
2003; Buchanan & Lovallo, 2001; Rimmele, Domes, Mathiak, &
Hautzinger, 2003), a similar effect on re-encoding does not come
as a surprise and is more likely than an effect on reconsolidation
following re-encoding, which should happen at a slower time scale
after memory reactivation (Nader & Hardt, 2009; Schiller & Phelps,
2011). Yet, we cannot rule out the alternative explanation that the
persistence of the memory impairment may be due to the lack of
cortisol required for modulation of the reconsolidation process,
which would likewise become evident in a subsequent retrieval.
Indeed recent studies suggest that cortisol (corticosterone in
rodents) via MRs or GRs may play a role not only in consolidation,
but also in reconsolidation processes (Akirav & Maroun, 2013;
Kruk, Haller, Meelis, & de Kloet, 2013; Taubenfeld, Riceberg, New,
& Alberini, 2009).
Considering the importance of re-encoding processes for the
long-term retention of memory, the observation of a persistently
reduced emotional memory retrieval after suppressing cortisol
during retrieval bears important clinical implications. Retrieval in
conditions of suppressed cortisol release might be a method to per-
manently weaken unwanted memories, for example, in patients
with posttraumatic stress disorder.Acknowledgments
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